BeOne Medicines (ONC) said Thursday it plans to invest $300 million to expand its flagship clinical and commercial-stage manufacturing and research and development center at the Princeton West Innovation Campus in Hopewell, New Jersey.
The expansion will advance BeOne's oncology pipeline of more than 35 clinical and commercial-stage assets, the company said.
The investment will fund the construction of a new three-story, 145,000-square-foot building near BeOne's existing Hopewell facilities, increasing the total campus footprint to about 545,000 square feet, the company added.
Price: $322.62, Change: $+2.69, Percent Change: +0.84%